Biostatistics, Design, Leadership Skill, Machine learning techniques, Oncology, Planning and organization, SLA, Statistics, Teamwork
The Chief Medical Affairs Office’s Evidence Generation (EvGen) Platform is responsible for establishing global scientific leadership and stature through the generation of integrated, end-to-end observational real-world evidence serving all therapeutic areas from proof of concept (POC) trials through LOE for priority pipeline candidates, pipeline supplementation through business development, and marketed inline products. The Platform fully centralizes RWE, epidemiology, outcomes research, RW-relevant health informatics, and biostatistics talent from global, international developed market (IDM) and emerging markets (EM) into one team to drive efficiency through internalized work.
The Platform functions to:
support competitive differentiation.
RWE, other patient-centric evidence, and RWI will be generated by the Platform for all global, prioritized IDM and prioritized EM needs through a combinatorial approach of cutting edge retrospective data analyses, site-based evaluations (e.g., Phase IV observational effectiveness studies, burden of illness, transmission, pathogenesis, risk factors for illness, determinants of product effectiveness and other studies), application of novel methods and technologies, and supplementation of interventional trials where appropriate with RWE through hybrid trial designs and tokenization.
The opportunity: This role is for a unique leader who is able to direct and manage teams and lead through influence across a wide variety of business verticals across the lifecycle, understand highly technical WE/Epidemiology/Statistical/Advanced Methods opportunities and communicate them to diverse audiences who lack expertise, create business plans and proposals, exhibit a high social IQ, and has deep experience with demonstrated history of success with global regulatory authorities, HTAs, and other stakeholders.
It plays a critical role in the development of a comprehensive RWE strategy, tactical plans, and projects that meet research and business needs at the global, regional and local level for priority markets worldwide. They are key members of multiple layers of lifecycle and franchise or asset governance. They will also provide matrixed leadership and oversight of all projects executed by Oncology RWE Science & Epidemiology and Clinical Affairs & Operations teams, restructuring priorities as needed based on shifting priorities for R&D and the business. To carry out this work, they will be responsible for maintaining relationships with Oncology leadership (CxO, SVP and VP) from research, biopharma business and business innovation. Finally, they will be an internationally-renowned external face of Pfizer, representing the organization and team at global industry events, conferences and symposia.
The position will lead a rapidly growing team through DP3, operational plans and the Seagen Integration of 5 individual contributor Sr Director Oncology RWE Strategic Planning franchise leaders dedicated to supporting the development of an Integrated Evidence Plan beginning on or before POC through LOE, evolving that plan & incorporating into relevant governance documents, accelerating and strengthening access for patients in priority markets worldwide with Global & Country Access and Value colleagues, ensuring that work by execution arms (RWE Science & Epidemiology for retrospective studies and Clinical Affairs for site-based prospective studies) is consistent with strategy, and other duties. They will also lead cross-functional teams to consider myriad scenarios to proactively create alternative solutions based on headwinds and tailwinds. The Head serve as single point of contact for all RWE planning readiness, strategic planning & tactical priority needs, incorporation of ex-US country CMAO colleagues’ feedback into strategies and tactics wherever applicable, ensuring that RWE Strategies equate to high ROI and actionable project plans, and identifies novel innovation & efficiency opportunities. They will serve as or assign duties as the Platform representative on all applicable Oncology franchise and asset governance committees (Global Product Teams, SLAC, Medical Strategy Teams, Integrated Value and Access Teams, etc.) across the lifecycle.
They will be responsible for directing their team to co-create integrated evidence plans early in the product lifecycle with cross-functional partners, ensuring that the IEP is appropriately documented in digital systems, maintaining and versioning those IEPs, calculating the ROI for each RWE project, providing guidance to execution teams on the best methodological approaches and study designs, providing feedback on tactic and project feasibility, selecting appropriate real world databases, and ultimately for delivering upon all in-scope evidence. They will monitor their teams’ performance and report metrics, challenges and opportunities back to their leader.
They also will be responsible for ensuring their direct reports oversee the work of execution teams to generate high quality and compliant evidence using retrospective RWD sources, technology-based direct-from-patient approaches for observational, site-based observational trials, and hybrid interventional / RWE trials. To do so, they will work in highly-matrixed cross-functional leadership teams and oversee study concepts, protocols to ensure robust designs, leverage knowledge of RWD and data standards, incorporate knowledge of standard of care and endpoints for given categories, and help interpret and disseminate results as part of cross-functional teams. The lead will also direct their reports and “dotted line reporting” Oncology-dedicated execution team members to rapidly communicate successes, publications, external speaking engagements, and lessons learned to the EvGen Impact Translation lead.
This leader will also work across other Platform capabilities’ senior leaders and in collaborations with Platform peers including VPs and other Heads of Evidence Strategic Planning, Head of Business Operations, the Oncology RWE Science & Epidemiology team lead, Oncology team leads for RWE Clinical Affairs & Clinical Operations, Study Quality & Compliance, and RWE Platforms & Partnerships.
Outside of the Platform, the colleague will work with senior executive leaders from R&D, Portfolio Management, CMAOs, Medical Affairs Strategy, Biostatistics & Data Management, Global Regulatory Affairs, Clinical Pharmacology / Pharmacometrics, Market Access, Business Assessment & Development, Digital, Legal/Compliance, and others to achieve research and business objectives.
They will also serve as an external face for Pfizer, providing expert epidemiological, statistical, methodological and execution excellence knowledge to its leaders. They will also serve as a trusted expert with study / analytical KOLs, key regulatory agencies (e.g., FDA in the US, EMA in Europe, MHRA in the UK, PDMA in Japan, CDE in China), HTAs/Payers, and other stakeholders.
ROLE RESPONSIBILITIES
REQUIRED EXPERIENCE, TRAINING AND EDUCATION
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
PREFERRED QUALIFICATIONS
Other Job Details:
LI-PFE
The annual base salary for this position ranges from $226,200.00 to $377,000.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues.
Hubei, China
2-4 year
Shanghai, China
2-4 year
Chortiatis, Thessaloniki, Greece
2-4 year
Chortiatis, Thessaloniki, Greece
2-4 year
Mumbai, Maharashtra, India
2-4 year
Tokyo, Japan
2-4 year
Chennai, Tamil Nadu, India
2-4 year
Chennai, Tamil Nadu, India
2-4 year
Peapack and Gladstone, NJ, USA
2-4 year
Peapack and Gladstone, NJ, USA
2-4 year
La Jolla, San Diego, CA, USA
2-4 year
Park Avenue, Brooklyn, NY, USA
2-4 year
Chennai, Tamil Nadu, India
2-4 year
San José Province, Escazu, Costa Rica
6-8 year
Chennai, Tamil Nadu, India
4-6 year
Berlin, Germany
4-6 year
Chennai, Tamil Nadu, India
4-6 year
Thessaloniki, Greece
2-4 year
Athens, Greece
2-4 year
La Jolla, San Diego, CA, USA
10-12 year
Collegeville, PA, USA
10-12 year
New York City, NY, USA
10-12 year
San Francisco, CA, USA
10-12 year
Cambridge, MA, USA
10-12 year
South San Francisco, CA, USA
10-12 year
Parsippany-Troy Hills, NJ, USA
0-2 year
New York City, NY, USA
16-18 year
La Jolla, San Diego, CA, USA
16-18 year
Lake Forest, IL, USA
16-18 year
Collegeville, PA, USA
16-18 year
Cambridge, MA, USA
16-18 year
Montreal, QC, Canada
16-18 year
Montreal, QC, Canada
8-10 year
New York, NY, USA
8-10 year
La Jolla, San Diego, CA, USA
8-10 year
Lake Forest, IL, USA
8-10 year
Boulder, CO, USA
8-10 year
Bothell, WA, USA
8-10 year
Collegeville, PA, USA
8-10 year
Cambridge, MA, USA
8-10 year
Groton, CT, USA
8-10 year
Montreal, QC, Canada
8-10 year
La Jolla, San Diego, CA, USA
8-10 year
Lake Forest, IL, USA
8-10 year
Collegeville, PA, USA
8-10 year
Pylaia, Thessaloniki, Greece
6-8 year
New York, NY, USA
8-10 year
Buenos Aires, Argentina
8-10 year
São Paulo, Brazil
8-10 year
New York, NY, USA
10-12 year
La Jolla, San Diego, CA, USA
10-12 year
Boulder, CO, USA
10-12 year
Bothell, WA, USA
10-12 year
Collegeville, PA, USA
10-12 year
Cambridge, MA, USA
10-12 year
Groton, CT, USA
10-12 year
Lake Forest, IL, USA
10-12 year
Montreal, QC, Canada
10-12 year
Montreal, QC, Canada
12-14 year
New York, NY, USA
12-14 year
La Jolla, San Diego, CA, USA
12-14 year
Boulder, CO, USA
12-14 year
Bothell, WA, USA
12-14 year
Collegeville, PA, USA
12-14 year
Cambridge, MA, USA
12-14 year
Groton, CT, USA
12-14 year
Lake Forest, IL, USA
12-14 year
Walton Oaks, Dorking Road, Tadworth, UK
10-12 year
La Jolla, San Diego, CA, USA
16-18 year
La Jolla, San Diego, CA, USA
8-10 year